Semaglutide Sodium

Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).
Supplier Selleck Chemicals
Product # S9697
Sku # S9697-1mg
Pricing 1mg, $270.00
Feedback